Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006
NCT00695357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 832
Last updated 2009-04-30
Summary
Cross-sectional, one visit study. All the data will be collected through questionnaires. Descriptives statistics will be applied to the data. 832 patients will participate to the study and 104 physicians.
Conditions
- New Strategies
- GINA 2006
- Patient Opinion
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Zachariadis Manolis, MD · Euroclinic, Athens, Greece
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-04-30
- Completion
- 2008-06-30
Countries
- Greece
Study Locations
More Related Trials
-
Effects of Hypolipemic Treatment on Adipokines
NCT01099176 ·Status: COMPLETED ·Phase: NA
-
Genetic Influence on Statin Pharmacodynamics
NCT01569854 ·Status: WITHDRAWN
-
Dyslipidemia of Obesity Intervention in Teens
NCT02956590 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides
NCT00108511 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
NCT03696940 ·Status: UNKNOWN ·Phase: PHASE3
-
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
NCT00361283 ·Status: COMPLETED ·Phase: PHASE4
-
Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin
NCT01785615 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology
NCT01112670 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
NCT01287182 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin
NCT01163851 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins
NCT01859455 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
NCT06262685 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effect of Genetic Variation on Efficacy and Safety of Lipid-Lowering Drugs
NCT07008794 ·Status: COMPLETED
-
Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
NCT00359281 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin
NCT00973986 ·Status: COMPLETED ·Phase: PHASE1
-
The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.
NCT00656331 ·Status: WITHDRAWN ·Phase: NA
-
Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events
NCT01770210 ·Status: COMPLETED
-
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers
NCT01115985 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Interaction Study Between TMC435, Atorvastatin and Simvastatin in Healthy Participants
NCT01689623 ·Status: COMPLETED ·Phase: PHASE1
-
Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis
NCT05511766 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia
NCT05852431 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia
NCT06173570 ·Status: COMPLETED ·Phase: PHASE2
-
Study of A3309 in Patients With Dyslipidemia
NCT01069783 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
NCT05900141 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3